OUR PROJECTS

DENVER – January 7, 2016: Three Leaf Ventures, an affiliate of The Broe Group established to invest in transformative healthcare technology, showed significant progress in 2015. Funds were delivered to several new companies and provided to existing investments to support their growth and progress. The firm plans to expand its focus on medical technology start-ups in the areas of genomics, telemedicine software and hardware, health IT, patient centered tools and services in 2016.

“2015 was a phenomenal year for Three Leaf Ventures. Our companies have made significant progress in terms of value growth. We continue to see tremendous potential from entrepreneurs taking a creative approach to addressing problems in our healthcare system and we expect 2016 will have no shortage of these opportunities,” said Sean Kearney, Managing Director of Three Leaf Ventures.

Highlights for 2015 include:

• Invested in the $35 million Series B Funding round of Scanadu Inc., the Silicon Valley based company that is building a platform of consumer tools and services including the creation of an FDA approved blood pressure device for consumers.
• Participated in the seed investment round of $2 million for Cohero Health, a digital health company focused on developing connected health tools and technologies to empower respiratory patients and improve care through smart mobile devices
• The Initial Public Offering of Invitae, a San Francisco-based genetic information company that Three Leaf Ventures supported in a round of private funding.
• Cypher Genomics, a genome informatics firm Three Leaf Ventures invested in, was acquired by Human Longevity, a genomics-based, technology-driven company.

“We are at the start of what will be a transformative era for how we view and manage our individual health. I am excited about the innovations that are only beginning to take place in medicine and related fields,” said Kiki Broe, Senior Associate at Three Leaf Ventures.

About Three Leaf Ventures

Three Leaf Ventures, the technology investment affiliate of The Broe Group, supports growing companies in their effort to address the many issues that exist in managing health. Today, as never before, technology can be leveraged to significantly reduce the frictions present in our healthcare system.  Three Leaf Ventures and The Broe Group aim to partner with entrepreneurs from vision to fruition.

About The Broe Group

The Broe Group and its affiliates, based in Denver, Colorado, employ more than 1,000 people and manage real estate throughout North America. Its transportation affiliate, OmniTRAX, Inc., is a leading logistics services firm with railroad, port and terminal operations throughout North America, including the Great Western Railway Company. Its energy affiliate, Great Western Oil & Gas Company, is a top 100 driller in the U.S. For more information, see www.broe.com.

Media Contacts:

Sean Kearney, Managing Director
Three Leaf Ventures
Email: skearney@threeleafventures.com
Phone: 303.298.0443

Ron Margulis
RAM Communications
Email: ron@rampr.com
Phone: 908-337-0020

Creator of innovative respiratory disease management platform closes seed round, led by Blue Cross Blue Shield of Massachusetts’ Zaffre Investments.

NEW YORK, NY

December 15, 2015

Cohero Health, a digital health company focused on developing connected health tools and technologies to empower respiratory patients and improve care through smart mobile devices, has announced that they closed a seed investment round of 2 million dollars. Key investors include Zaffre Investments, the investment arm of Blue Cross Blue Shield of Massachusetts, Three Leaf Ventures an affiliate of the Broe Group, Bioadvance and Swanhill Capital. StartUp Health, of which Cohero Health is a member, also participated via their digital health syndicate on AngelList.

Cohero Health’s connected devices and mobile applications actively engage and empower respiratory patients by measuring lung function and tracking adherence. The company’s proprietary platform comprises wireless medication inhaler sensors to track patient adherence, an FDA cleared mobile spirometer to measure lung function, mobile applications to engage patients, generate custom reminders and reward compliance, and access to custom data via HIPAA-compliant servers to support robust patient monitoring.

Cohero Health is the first and only company to enable tracking of controller medication, rescue medication and discern lung function in real-time, in an integrated comprehensive model. The company is poised to transform care of asthma and COPD patients through improved selfmanagement, and by empowering clinicians with critical components of optimal respiratory care, knowing how patients are using their medication and how they are responding.

Cohero Health has successfully deployed its platform at Mount Sinai Health System and Dartmouth-Hitchcock Medical Center, and plans to announce more partnerships before year’s end. Early results have shown a 2.5 times increase in medication adherence over standard of care, and 100% reduction in hospitalizations. “We are committed to building a platform that is dedicated to the key challenges faced by the respiratory community,” said Melissa Manice, PhD, Co-Founder. “Cohero Health connects patients to care providers in an unprecedented way, allowing for the many stakeholders in the respiratory community to benefit from a tool that addresses proactive treatment compliance and mobile lung function monitoring. The funds raised and depth of expertise of our strategic investors allow us to ramp up manufacturing and bring us to full commercial readiness to meet current customer demand.” “We are dedicated to advancing health care companies that help people become more informed and engaged in their health and wellbeing,” said Steve Agular, Managing Director at Zaffre Investments. “This partnership is an exciting opportunity, as the Cohero Health platform has proven to show a real benefit to consumers dealing with respiratory issues and has led to improved health outcomes.” The company plans to use the funding to scale production of its devices to support large customer deployments, and the full-scale commercial launch of its platform.

About Cohero Health, LLC

Cohero Health is a digital health company developing innovative tools and technologies to improve respiratory care, reduce avoidable costs and optimize medication use. The company’s connected devices and mobile applications actively engage and empower respiratory patients by measuring lung function and tracking adherence. Based in New York, the company is a member of StartUp Health, Springboard Enterprises, and Grand Central Tech.

…Three Leaf Ventures, a wholly-owned subsidiary of The Broe Group established to invest in progressive healthcare technology companies, is opening…

…should read: Three Leaf Ventures, an affiliate of The Broe Group established to invest in progressive healthcare technology companies, is opening…

…should read: Three Leaf Ventures, an affiliate of The Broe Group established to invest in progressive healthcare technology companies, is opening…

…Wire)–Three Leaf Ventures, a wholly-owned subsidiary of The Broe Group established to invest in progressive healthcare technology companies, is opening…

Redmile Group, Ame Cloud Ventures and Three Leaf Ventures, an affiliate of The Broe Group. With this round, Scanadu has raised $49.7 million in…

…Group, Ame Cloud Ventures and Three Leaf Ventures, an affiliate of The Broe Group, also participated. Scanadu has now raised USD49.7 million in…